Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 1/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | CTSC | P53634 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.30 |
| ▸ | MASP2 | O00187 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6988246 | 0.93 | ADAM17 (0.43) | ADAM17TGFBR1P2RX3CTSC | |
| SCHEMBL6984594 | 0.93 | ADAM17 (0.43) | ADAM17TGFBR1P2RX3CTSCMASP2 | |
| SCHEMBL6986902 | 0.91 | ADAM17 (0.42) | ADAM17TGFBR1P2RX3CTSC | |
| SCHEMBL6987554 | 0.91 | ADAM17 (0.42) | ADAM17TGFBR1P2RX3CTSCMASP2 | |
| SCHEMBL6982346 | 0.91 | ADAM17 (0.41) | ADAM17TGFBR1CTSC | |
| SCHEMBL6987483 | 0.90 | ADAM17 (0.41) | ADAM17TGFBR1CTSC | |
| SCHEMBL6986338 | 0.90 | ADAM17 (0.41) | ADAM17TGFBR1 | |
| SCHEMBL6988681 | 0.90 | ADAM17 (0.43) | ADAM17TGFBR1P2RX3CTSC | |
| SCHEMBL6986737 | 0.90 | ADAM17 (0.43) | ADAM17TGFBR1P2RX3CTSCMASP2 | |
| SCHEMBL6979989 | 0.89 | ADAM17 (0.41) | ADAM17TGFBR1CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |